Literature DB >> 17627380

Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders.

Theresa A Beery1, Janet K Williams.   

Abstract

Although clinical genetic testing is available for over 1,000 inherited disorders, consequences of predictive genetic testing have been most extensively examined for hereditary breast and ovarian cancer (HBOC), hereditary colon cancer, and Huntington disease (HD). These focus primarily on psychological, ethical, legal, and social aspects of genetic testing. Genetic testing may also provide information that can lead to behaviors that promote health and reduce risk for disease, reflecting options available for the disorder for which the person is at risk. However, regardless of condition, people completing a genetic test may inform relatives about the results of the test and implications for their risk to develop the condition. Literature on risk reduction behaviors and communication focuses on families with HBOC or colorectal cancer. Few reports document behaviors for other conditions. This paper presents a systematic review of the research literature on risk reduction and health promotion behaviors following clinical genetic testing for adult onset conditions, primarily HBOC, familial colon cancers, and HD. Insights gleaned from this review are discussed as a basis for planning monitoring of health promotion and risk-reduction behaviors for genetic testing for present and future use.

Entities:  

Mesh:

Year:  2007        PMID: 17627380     DOI: 10.1089/gte.2006.0527

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  28 in total

1.  Points to consider in assessing and appraising predictive genetic tests.

Authors:  Wolf H Rogowski; Scott D Grosse; Jürgen John; Helena Kääriäinen; Alastair Kent; Ulf Kristofferson; Jörg Schmidtke
Journal:  J Community Genet       Date:  2010-10-16

Review 2.  Challenges of translating genetic tests into clinical and public health practice.

Authors:  Wolf H Rogowski; Scott D Grosse; Muin J Khoury
Journal:  Nat Rev Genet       Date:  2009-07       Impact factor: 53.242

3.  Introduction to the special issue: psychological aspects of genomics and child health.

Authors:  Kenneth P Tercyak
Journal:  J Pediatr Psychol       Date:  2008-12-06

Review 4.  Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.

Authors:  Kimberly A Kaphingst; Colleen M McBride
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

5.  Communication strategies for enhancing understanding of the behavioral implications of genetic and biomarker tests for disease risk: the role of coherence.

Authors:  Linda D Cameron; Theresa M Marteau; Paul M Brown; William M P Klein; Kerry A Sherman
Journal:  J Behav Med       Date:  2011-06-23

6.  Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.

Authors:  Sato Ashida; Laura M Koehly; J Scott Roberts; Clara A Chen; Susan Hiraki; Robert C Green
Journal:  J Health Commun       Date:  2009-12

7.  Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents.

Authors:  Lea Godino; Daniela Turchetti; Leigh Jackson; Catherine Hennessy; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2018-10-04       Impact factor: 4.246

8.  Family health information sharing among older adults: reaching more family members.

Authors:  Sato Ashida; Ellen J Schafer
Journal:  J Community Genet       Date:  2014-07-30

9.  The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling.

Authors:  Mary B Daly
Journal:  J Genet Couns       Date:  2008-08-08       Impact factor: 2.537

10.  Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.

Authors:  Astrid Rasmussen; Elisa Alonso; Adriana Ochoa; Irene De Biase; Itziar Familiar; Petra Yescas; Ana-Luisa Sosa; Yaneth Rodríguez; Mireya Chávez; Marisol López-López; Sanjay I Bidichandani
Journal:  BMC Med Genet       Date:  2010-01-12       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.